Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 1997
Digital Biotech Pvt Ltd has submitted the disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE26-10-2010
26-10-2010
Disclosures under Reg. 7(1A) of SEBI (SAST) Regulations, 1997
Allantis Exim Pvt Ltd has submitted the disclosure under Regulation 7(1A) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE25-10-2010
Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 1997
Advent Tradelink Pvt Ltd has submitted the disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE23-10-2010
Outcome of Board Meeting
Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 15, 2010, has allotted 50,00,000 equity shares of Rs. 10/- each for cash at premium of Rs. 31/- per share to the four different entities on a preferential basis.15-10-2010
Board Meeting on Oct 15, 2010
Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 15, 2010, to allot the 50,00,000 equity shares of Rs. 10/- each at premium of Rs. 31/- per share on preferential basis to promoters and non promoters entitles.13-10-2010
Disclosures under Reg. 8A of SEBI (SAST) Regulations, 1997
Lincoln Pharmaceuticals Ltd has submitted the disclosure under Regulation 8A of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSEDate of Reporting : September 30, 2010Name of the Company : Lincoln Pharmaceuticals LtdTotal no of outstanding shares of the Company : 11310800Name of the Entity : Gulabdas I Patel...05-10-2010
Outcome of AGM
Lincoln Pharmaceuticals Ltd has informed BSE that the members at the Annual General Meeting (AGM) of the Company held on September 30, 2010, inter alia, have passed the following resolutions:1. Adoption of the audited Balance Sheet as at March 31, 2010 and Profit and Loss Account for the year ended on that date and Report of the Director and Auditors there on....30-09-2010
Outcome of Board Meeting
Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 31, 2010, inter alia, has approved the following:1. Increase the authorized share capital from Rs. 12 Crores to Rs. 20 Crores subject to approval by members at AGM.2. Approved the issue of total 50,00,000 (Fifty lacs), equity shares of Rs. 10/- each on preferential basis as per SEBI (issue of Capital and Disclosure...31-08-2010
Board Meeting on Aug 31, 2010
Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 31, 2010, inter alia, to consider the following :1. To increase in authorised share capital from Rs. 12 Crores to Rs. 20 Crores.2. To consider and decide about issue of 50,00,000 equity shares Rs. 10/- each to promoters / their associates / entities other than promoters on preferential basis as per applicable SEBI guidelines.26-08-2010
Fixes Book Closure for Dividend & AGM
Lincoln Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 25, 2010 to September 30, 2010 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company.21-08-2010